Displaying 1 - 2 of 2
| Active Ingredient | DORZOLAMIDE |
| Therapeutic Class | EENT CARBONIC ANHYDRASE INHIBITORS |
| Indications | Management of open-angle glaucoma, pseudo-exfoliative glaucoma, and ocular hypertension, either alone or as an adjunct to a topical beta blocker. |
| Caution | Bitter taste, headache, asthenia, ocular irritation, blurred vision, lacrimation, conjunctivitis. |
| Dose Range | Adult: 1-2 drops 3 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DORZOLAMIDE | TIMOLOL |
| Therapeutic Class | ANTIGLAUCOMA AGENTS MISCELLANEOUS |
| Indications | Ocular hypertension in patients who are insufficiently responsive to betablockers. Open angle glaucoma. |
| Caution | Nausea, vomiting, headache, vasoconstricton, palpitations. Not recommended for use in patients with bronchial asthma, history of bronchial asthma, or severe chronic obstructive pulmonary disease More ... |
| Dose Range |
1 drop in affected eye(s) twice daily . See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |